August 01, 2023
On July 11, the 2023 Fortune China 500 List, compiled by Fortune (Chinese edition) and CICC, was released. The list reflects the performance and achievements of the world's largest Chinese-listed companies over the past year.
CSPC was again included in the list and ranked 403rd, up 19 places from last year.
The 500 Chinese listed companies have a total revenue of RMB 65.8 trillion and a net profit of RMB 4.7 trillion. The annual revenue threshold of the companies on the list is close to RMB 23.7 billion.
While establishing a diversified product system and deeply cultivating three major sectors, including OTCs, APIs and functional foods, CSPC exports its products to more than 100 countries and regions around the world. Moreover, CSPC has deeply built a global industrial chain to safeguard the safety and stability of the international pharmaceutical industry chain.